One Johnson & Johnson Plaza
New Brunswick, NJ
Phone: 7325240400
Fax: 7322140332
|
CEO: Ralph S. Larsen
Exchange: NYSE
Industry: Drug Manufacturers/Major |
|
|
Johnson & Johnson is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. The company's worldwide business is divided into three segments: Consumer; Pharmaceutical; and Professional.
|
|
| Current Price: |
$0.00 |
| 52 Week High: |
N/A |
| 52 Week Low: |
N/A |
| 5 Year High: |
$57.60 |
| 5 Year Low: |
$20.78 |
| Beta: |
0.31 |
|
| Market Cap: |
$0.0 Mil |
| Shares Outstanding: |
2.9 Mil |
| Insider Ownership: |
N/A |
| Institutional Ownership: |
61.7% |
| Short Interest Shares: |
41,501,873 |
| Short Interest Ratio: |
5.6 |
|
| 12 Month EPS: |
$1.77 |
| PE Ratio: |
0.0 |
| Book Value: |
$7.28 |
| Price/Book Value: |
0.0 |
| Dividend: |
$0.72 |
| Dividend Yield: |
2.811% |
|
| Profit Margin: |
16.90% |
| Return on Equity: |
22.60% |
| Return on Assets: |
14.20% |
| Debt to Equity: |
0.11 |
| Interest Coverage: |
55.5 |
| Dividend Payout: |
|
|
